BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
MYC
,
Apoptosis
,
Pseudomonas infection
,
Adipose tissue
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PAS domain superfamily
(biogroup)
NextBio Summary
General Info
Body Atlas
Most Correlated Tissues
Saphenous vein
Thymus gland
Esophagus
Parietal lobe
Plasma cell of spleen
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Bordetellosis
Disease due to Orthopoxvirus
Measles
Alpha-1-antitrypsin deficiency
Disorder of digestive system
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
Cyclandelate
CGP 60474
Nisoldipine
tosufloxacin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
hsa-miR-365a-3p
TLK2
MTAP
MFAP2
JUN
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Liver Pharmacology and Xenobiotic Response Repertoire
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
The Cancer Genome Atlas (TCGA) - gene expression in glioblastoma multiforme
L1000 CMAP - Prostate cancer PC3.101 cells with CRISPR-targeted gene knockouts
L1000 CMAP - Colorectal cancer HT29.311 cells with CRISPR-targeted gene knockouts
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for PAS domain superfamily
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A First-in-human Study of ILDR2 (Immunoglobulin-like Domain Containing Receptor 2) Function-blocking…
Pembrolizumab in First Line Treatment of Advanced NSCLC Patients With PD-L1 Low Tumors.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ